The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Single-Use Technology for Biopharmaceuticals-Global Market Insights and Sales Trends 2024
Synopsis
A biopharmaceutical is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.
The global Single-Use Technology for Biopharmaceuticals market size is expected to reach US$ 8472.9 million by 2029, growing at a CAGR of 9.9% from 2023 to 2029. The market is mainly driven by the significant applications of Single-Use Technology for Biopharmaceuticals in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Single-Use Technology for Biopharmaceuticals market. Protective Clothing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Syringes segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Single-Use Technology for Biopharmaceuticals, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Single-Use Technology for Biopharmaceuticals market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Single-Use Technology for Biopharmaceuticals market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Single-Use Technology for Biopharmaceuticals sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Single-Use Technology for Biopharmaceuticals covered in this report include Applikon Biotechnology, BioPure Technology, DowDuPont, EMD Millipore, GE Healthcare, Novasep, Pall, Saint-Gobain and Sartorius, etc.
The global Single-Use Technology for Biopharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Applikon Biotechnology
BioPure Technology
DowDuPont
EMD Millipore
GE Healthcare
Novasep
Pall
Saint-Gobain
Sartorius
Thermo Fisher Scientific
W. L. Gore and Associates
Global Single-Use Technology for Biopharmaceuticals market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Single-Use Technology for Biopharmaceuticals market, Segment by Type:
Protective Clothing
Syringes
Pipettes and Pipette Tips
Flasks, Dishes, Sample and Centrifuge Vials
Simple Cultivation Systems
Global Single-Use Technology for Biopharmaceuticals market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Single-Use Technology for Biopharmaceuticals companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A biopharmaceutical is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.
The global Single-Use Technology for Biopharmaceuticals market size is expected to reach US$ 8472.9 million by 2029, growing at a CAGR of 9.9% from 2023 to 2029. The market is mainly driven by the significant applications of Single-Use Technology for Biopharmaceuticals in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Single-Use Technology for Biopharmaceuticals market. Protective Clothing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Syringes segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Single-Use Technology for Biopharmaceuticals, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Single-Use Technology for Biopharmaceuticals market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Single-Use Technology for Biopharmaceuticals market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Single-Use Technology for Biopharmaceuticals sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Single-Use Technology for Biopharmaceuticals covered in this report include Applikon Biotechnology, BioPure Technology, DowDuPont, EMD Millipore, GE Healthcare, Novasep, Pall, Saint-Gobain and Sartorius, etc.
The global Single-Use Technology for Biopharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Applikon Biotechnology
BioPure Technology
DowDuPont
EMD Millipore
GE Healthcare
Novasep
Pall
Saint-Gobain
Sartorius
Thermo Fisher Scientific
W. L. Gore and Associates
Global Single-Use Technology for Biopharmaceuticals market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Single-Use Technology for Biopharmaceuticals market, Segment by Type:
Protective Clothing
Syringes
Pipettes and Pipette Tips
Flasks, Dishes, Sample and Centrifuge Vials
Simple Cultivation Systems
Global Single-Use Technology for Biopharmaceuticals market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Single-Use Technology for Biopharmaceuticals companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Single-Use Technology for Biopharmaceuticals
1.1 Single-Use Technology for Biopharmaceuticals Market Overview
1.1.1 Single-Use Technology for Biopharmaceuticals Product Scope
1.1.2 Single-Use Technology for Biopharmaceuticals Market Status and Outlook
1.2 Global Single-Use Technology for Biopharmaceuticals Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Single-Use Technology for Biopharmaceuticals Market Size by Region (2018-2029)
1.4 Global Single-Use Technology for Biopharmaceuticals Historic Market Size by Region (2018-2023)
1.5 Global Single-Use Technology for Biopharmaceuticals Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Single-Use Technology for Biopharmaceuticals Market Size (2018-2029)
1.6.1 North America Single-Use Technology for Biopharmaceuticals Market Size (2018-2029)
1.6.2 Europe Single-Use Technology for Biopharmaceuticals Market Size (2018-2029)
1.6.3 Asia-Pacific Single-Use Technology for Biopharmaceuticals Market Size (2018-2029)
1.6.4 Latin America Single-Use Technology for Biopharmaceuticals Market Size (2018-2029)
1.6.5 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size (2018-2029)
2 Single-Use Technology for Biopharmaceuticals Market by Type
2.1 Introduction
2.1.1 Protective Clothing
2.1.2 Syringes
2.1.3 Pipettes and Pipette Tips
2.1.4 Flasks, Dishes, Sample and Centrifuge Vials
2.1.5 Simple Cultivation Systems
2.2 Global Single-Use Technology for Biopharmaceuticals Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Single-Use Technology for Biopharmaceuticals Historic Market Size by Type (2018-2023)
2.2.2 Global Single-Use Technology for Biopharmaceuticals Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Single-Use Technology for Biopharmaceuticals Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Single-Use Technology for Biopharmaceuticals Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Single-Use Technology for Biopharmaceuticals Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Single-Use Technology for Biopharmaceuticals Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Single-Use Technology for Biopharmaceuticals Revenue Breakdown by Type (2018-2029)
3 Single-Use Technology for Biopharmaceuticals Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Single-Use Technology for Biopharmaceuticals Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Single-Use Technology for Biopharmaceuticals Historic Market Size by Application (2018-2023)
3.2.2 Global Single-Use Technology for Biopharmaceuticals Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Single-Use Technology for Biopharmaceuticals Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Single-Use Technology for Biopharmaceuticals Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Single-Use Technology for Biopharmaceuticals Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Single-Use Technology for Biopharmaceuticals Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Single-Use Technology for Biopharmaceuticals Revenue Breakdown by Application (2018-2029)
4 Single-Use Technology for Biopharmaceuticals Competition Analysis by Players
4.1 Global Single-Use Technology for Biopharmaceuticals Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Single-Use Technology for Biopharmaceuticals as of 2022)
4.3 Date of Key Players Enter into Single-Use Technology for Biopharmaceuticals Market
4.4 Global Top Players Single-Use Technology for Biopharmaceuticals Headquarters and Area Served
4.5 Key Players Single-Use Technology for Biopharmaceuticals Product Solution and Service
4.6 Competitive Status
4.6.1 Single-Use Technology for Biopharmaceuticals Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Applikon Biotechnology
5.1.1 Applikon Biotechnology Profile
5.1.2 Applikon Biotechnology Main Business
5.1.3 Applikon Biotechnology Single-Use Technology for Biopharmaceuticals Products, Services and Solutions
5.1.4 Applikon Biotechnology Single-Use Technology for Biopharmaceuticals Revenue (US$ Million) & (2018-2023)
5.1.5 Applikon Biotechnology Recent Developments
5.2 BioPure Technology
5.2.1 BioPure Technology Profile
5.2.2 BioPure Technology Main Business
5.2.3 BioPure Technology Single-Use Technology for Biopharmaceuticals Products, Services and Solutions
5.2.4 BioPure Technology Single-Use Technology for Biopharmaceuticals Revenue (US$ Million) & (2018-2023)
5.2.5 BioPure Technology Recent Developments
5.3 DowDuPont
5.3.1 DowDuPont Profile
5.3.2 DowDuPont Main Business
5.3.3 DowDuPont Single-Use Technology for Biopharmaceuticals Products, Services and Solutions
5.3.4 DowDuPont Single-Use Technology for Biopharmaceuticals Revenue (US$ Million) & (2018-2023)
5.3.5 EMD Millipore Recent Developments
5.4 EMD Millipore
5.4.1 EMD Millipore Profile
5.4.2 EMD Millipore Main Business
5.4.3 EMD Millipore Single-Use Technology for Biopharmaceuticals Products, Services and Solutions
5.4.4 EMD Millipore Single-Use Technology for Biopharmaceuticals Revenue (US$ Million) & (2018-2023)
5.4.5 EMD Millipore Recent Developments
5.5 GE Healthcare
5.5.1 GE Healthcare Profile
5.5.2 GE Healthcare Main Business
5.5.3 GE Healthcare Single-Use Technology for Biopharmaceuticals Products, Services and Solutions
5.5.4 GE Healthcare Single-Use Technology for Biopharmaceuticals Revenue (US$ Million) & (2018-2023)
5.5.5 GE Healthcare Recent Developments
5.6 Novasep
5.6.1 Novasep Profile
5.6.2 Novasep Main Business
5.6.3 Novasep Single-Use Technology for Biopharmaceuticals Products, Services and Solutions
5.6.4 Novasep Single-Use Technology for Biopharmaceuticals Revenue (US$ Million) & (2018-2023)
5.6.5 Novasep Recent Developments
5.7 Pall
5.7.1 Pall Profile
5.7.2 Pall Main Business
5.7.3 Pall Single-Use Technology for Biopharmaceuticals Products, Services and Solutions
5.7.4 Pall Single-Use Technology for Biopharmaceuticals Revenue (US$ Million) & (2018-2023)
5.7.5 Pall Recent Developments
5.8 Saint-Gobain
5.8.1 Saint-Gobain Profile
5.8.2 Saint-Gobain Main Business
5.8.3 Saint-Gobain Single-Use Technology for Biopharmaceuticals Products, Services and Solutions
5.8.4 Saint-Gobain Single-Use Technology for Biopharmaceuticals Revenue (US$ Million) & (2018-2023)
5.8.5 Saint-Gobain Recent Developments
5.9 Sartorius
5.9.1 Sartorius Profile
5.9.2 Sartorius Main Business
5.9.3 Sartorius Single-Use Technology for Biopharmaceuticals Products, Services and Solutions
5.9.4 Sartorius Single-Use Technology for Biopharmaceuticals Revenue (US$ Million) & (2018-2023)
5.9.5 Sartorius Recent Developments
5.10 Thermo Fisher Scientific
5.10.1 Thermo Fisher Scientific Profile
5.10.2 Thermo Fisher Scientific Main Business
5.10.3 Thermo Fisher Scientific Single-Use Technology for Biopharmaceuticals Products, Services and Solutions
5.10.4 Thermo Fisher Scientific Single-Use Technology for Biopharmaceuticals Revenue (US$ Million) & (2018-2023)
5.10.5 Thermo Fisher Scientific Recent Developments
5.11 W. L. Gore and Associates
5.11.1 W. L. Gore and Associates Profile
5.11.2 W. L. Gore and Associates Main Business
5.11.3 W. L. Gore and Associates Single-Use Technology for Biopharmaceuticals Products, Services and Solutions
5.11.4 W. L. Gore and Associates Single-Use Technology for Biopharmaceuticals Revenue (US$ Million) & (2018-2023)
5.11.5 W. L. Gore and Associates Recent Developments
6 North America
6.1 North America Single-Use Technology for Biopharmaceuticals Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Single-Use Technology for Biopharmaceuticals Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Single-Use Technology for Biopharmaceuticals Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Single-Use Technology for Biopharmaceuticals Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Single-Use Technology for Biopharmaceuticals Market Dynamics
11.1 Single-Use Technology for Biopharmaceuticals Industry Trends
11.2 Single-Use Technology for Biopharmaceuticals Market Drivers
11.3 Single-Use Technology for Biopharmaceuticals Market Challenges
11.4 Single-Use Technology for Biopharmaceuticals Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
